Here's Why There's Been A Rush Of Biotech Offerings By: Benzinga via Benzinga January 07, 2016 at 11:32 AM EST The beginning of the year has started with four consecutive sell-offs in the S&P 500. Sectors have been hit by a bevy topics ... Read More >> Related Stocks: Acadia Pharmaceutica Adamas Pharma Ardelyx Inc Epizyme Inc Nasdaq Biotechnology Ishares ETF Otonomy Inc Prothena Corp Sage Therapeutic Com